Comments on "Pretreatment [⁶⁸Ga]-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma" [0.03%]
关于“使用[⁶⁸Ga]-PSMA-11 PET/CT预处理预测免疫检查点抑制剂联合酪氨酸激酶抑制剂治疗转移性肾细胞癌反应”的评论
Dongdong Zhang,Junbin Zhang,Ming Cai
Dongdong Zhang
Access and Reimbursement for Artificial Intelligence in Radiology: A Macau Perspective [0.03%]
放射学中人工智能的获取和报销：澳门视角
Chon Man Ieong,Mei Leng Ieong,Soi Chau Kong
Chon Man Ieong
Radiological Approach to Splenomegaly: Etiologies, Pathophysiologies, and Diagnostic Strategies [0.03%]
放射学脾大的诊断方法：病因、病理生理和诊断策略
Na Yeon Han,Yong Park,Min Ju Kim
Na Yeon Han
The spleen is frequently referred to as the "silent and forgotten" organ of the abdomen by clinicians and radiologists, primarily because of the secondary nature of most splenic pathologies and their relative rarity compared with hepatic di...
Access and Reimbursement for Artificial Intelligence in Radiology: A Central Asian Perspective [0.03%]
放射科人工智能的获取和报销：中亚视角
Tairkhan Dautov,Ainara Darbaeva,Zhuldyz Aimagambetova et al.
Tairkhan Dautov et al.
Access and Reimbursement for Artificial Intelligence in Radiology in Mongolia [0.03%]
蒙古放射学中人工智能的获取和报销问题
Tuvshinjargal Dashjamts,Bayarbaatar Bold,Munkhbaatar Dagvasumberel et al.
Tuvshinjargal Dashjamts et al.
Access and Reimbursement for Artificial Intelligence in Radiology: A Japanese Perspective [0.03%]
日本放射科人工智能的准入和报销问题
Kenji Hirata,Mototaka Miyake,Kei Yamada
Kenji Hirata
Response to Comments on "Pretreatment [⁶⁸Ga]-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma" [0.03%]
“[⁶⁸Ga] PSMA-11 PET/CT在预测转移性肾细胞癌患者免疫检查点抑制剂联合酪氨酸激酶抑制剂治疗反应中的作用”一文的回信
Shao-Hao Chen,Xiao-Hui Wu,Qian-Ren-Shun Qiu et al.
Shao-Hao Chen et al.
Network Radiology as a New Paradigm in Radiology Practice: Recent Insights From Integrated Health Systems in the United States [0.03%]
网络放射学作为放射学实践的新范例：美国综合医疗体系的近期洞见
Woojin Yi,Hyo Jin Lee,Kyung Won Kim et al.
Woojin Yi et al.
Shin Mei Chan,Vitor F Martins,Kathleen Marsh et al.
Shin Mei Chan et al.
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease, is the fastest-growing cause of chronic liver disease worldwide, affecting approximately 30% of the global population. I...
Commentary on "Effects of Deep Learning-Based Reconstruction on the Quality of Accelerated Contrast-Enhanced Neck MRI" [0.03%]
关于“基于深度学习重建的加速强化剂增强颈部MRI质量的影响”的评论
Guimei Yuan,Yongliang Pang
Guimei Yuan